Results 271 to 280 of about 212,589 (324)
ABSTRACT Between 2020 and 2022 in the United Kingdom (UK), there were 45 maternal deaths from venous thromboembolism (VTE), out of more than 2 million maternities. This occurred despite extensive risk assessment and prescribing of low molecular weight heparin (LMWH) thromboprophylaxis, alongside clinicians' overestimate of risk and commitment to the ...
Laura A. Magee+9 more
wiley +1 more source
The association between deep vein thrombosis at admission and the time from injury to admission in hip fractures. [PDF]
Liu J, He M, Song R, Li J.
europepmc +1 more source
Interventional oncology in children: Where are we now?
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel+1 more
wiley +1 more source
The effect of AngioJet thrombectomy combined with catheter-directed thrombolysis in acute deep vein thrombosis of the lower extremities. [PDF]
Xue J+5 more
europepmc +1 more source
Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia
ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes+2 more
wiley +1 more source
ABSTRACT Frontal fibrosing alopecia (FFA) is a form of cicatricial alopecia that is being increasingly diagnosed in recent years. It predominantly affects post‐menopausal women of various ethnic backgrounds, but cases have also been reported in pre‐menopausal women and rarely in men.
Adrienne Oxenham, Annabel Stevenson
wiley +1 more source
An artificial intelligence interpretable tool to predict risk of deep vein thrombosis after endovenous thermal ablation. [PDF]
Tabari A+6 more
europepmc +1 more source
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller+13 more
wiley +1 more source
Assessment of Catheter-Directed Thrombolysis and Histotripsy Treatment for Deep Vein Thrombosis. [PDF]
Zhao K+14 more
europepmc +1 more source